Research location
Umhlanga
South Africa
Advertisement
Research activity in Umhlanga
South AfricaCureCurrent currently publishes aggregate city-level research activity for this location: 16 trials and 17 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Umhlanga
16 linked trials · page 1 of 1Rezafungin for Treatment of Pneumocystis Pneumonia in HIV AdultsNCT05835479 · 2023-11-14 · 1 site observation
RECRUITING
iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic DiseasesNCT03549754 · 2018-02-17 · 2 site observations
RECRUITING
A Study to Assess the Efficacy and Safety of Budesonide/Albuterol Metered-dose Inhaler (BDA MDI/PT027) in Adults and Children 4 Years of Age or Older With AsthmaNCT03769090 · 2018-12-13 · 1 site observation
COMPLETED
Observation of Clinical Routine Care for Heart Failure Patients Implanted With BIOTRONIK CRT DevicesNCT03366545 · 2018-05-14 · 1 site observation
ACTIVE_NOT_RECRUITING
Assessment of the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's TypeNCT03393520 · 2017-10-13 · 1 site observation
COMPLETED
A Study of LY3337641 in Rheumatoid ArthritisNCT02628028 · 2016-08-22 · 1 site observation
TERMINATED
Effect of Albiglutide, When Added to Standard Blood Glucose Lowering Therapies, on Major Cardiovascular Events in Subjects With Type 2 Diabetes MellitusNCT02465515 · 2015-07-01 · 1 site observation
COMPLETED
Study to Assess the Efficacy and Safety of PT010 Relative to PT003 and PT009 in Subjects With Moderate to Very Severe COPD (Ethos)NCT02465567 · 2015-06-30 · 1 site observation
COMPLETED
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHFNCT01870778 · 2013-10-02 · 1 site observation
COMPLETED
A Study in Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS) to Assess the Efficacy, Safety and Tolerability of Glatiramer Acetate (GA) Injection 40 mg Administered Three Times a Week Compared to PlaceboNCT01067521 · 2010-06-22 · 1 site observation
COMPLETED
Comparison of NN1250 With Sitagliptin in Subjects With Type 2 Diabetes Never Treated With InsulinNCT01046110 · 2010-01-01 · 1 site observation
COMPLETED
Effect of LY450139 on the Long Term Progression of Alzheimer's DiseaseNCT00594568 · 2008-03-01 · 1 site observation
COMPLETED
Long-term Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple SclerosisNCT00662649 · 2008-02-01 · 1 site observation
COMPLETED
ANDES-AGI-1067 as a Novel Antidiabetic Agent Evaluation StudyNCT00525577 · 2007-08-01 · 1 site observation
UNKNOWN
Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 DiabetesNCT00318422 · 2006-05-01 · 1 site observation
COMPLETED
The Efficacy, Safety and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor FluctuationsNCT00286897 · 2006-02-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.